Skip to main content
TVRD $1.83 +0.55%
TVRD logo
TVRD · Tvardi Therapeutics, Inc.
Track TVRD — free
$1.83 +0.01 (+0.55%) At close · Aug 31
Market Cap
$24.28M
Shares
13.34M
All earnings calls

Earnings call · FY2023 Q3

Tvardi Therapeutics, Inc. (TVRD) Q3 2023 Earnings Call

Concluded Nov 13, 2023
Nov 13, 2023 0 turns
Period
FY2023 Q3
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $4.87M -55% YoY
Diluted EPS -$18.72
Net income -$28.03M

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Collaborative Revenue$2.47M -66.8% YoY
Commercial Supply Revenue$1.25M -62.8% YoY
License and Milestone Fees$910,000
Royalty$167,000
Clinical Compound Revenue$66,000
Full-screen source Call document